<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id><journal-id journal-id-type="publisher-id">hmg</journal-id><journal-id journal-id-type="hwp">hmg</journal-id><journal-title-group><journal-title>Human Molecular Genetics</journal-title></journal-title-group><issn pub-type="ppub">0964-6906</issn><issn pub-type="epub">1460-2083</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21875899</article-id><article-id pub-id-type="pmc">3179381</article-id><article-id pub-id-type="doi">10.1093/hmg/ddr384</article-id><article-id pub-id-type="publisher-id">ddr384</article-id><article-categories><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Peden</surname><given-names>John F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Farrall</surname><given-names>Martin</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff><addr-line>Department of Cardiovascular Medicine</addr-line>, <institution>The Wellcome Trust Centre for Human Genetics, University of Oxford</institution>, <addr-line>Roosevelt Drive, Oxford OX3 7BN</addr-line>, <country>UK</country></aff><author-notes><corresp id="cor1"><label>*</label>To whom correspondence should be addressed. Tel: +<phone>44 1865287601</phone>; Fax: +<fax>44 1865287501</fax>; Email: <email>martin.farrall@cardiov.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>10</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>29</day><month>8</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>8</month><year>2011</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>20</volume><issue>R2</issue><fpage>R198</fpage><lpage>R205</lpage><history><date date-type="received"><day>24</day><month>6</month><year>2011</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2011</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2011. Published by Oxford University Press</copyright-statement><copyright-year>2011</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.5/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.5">http://creativecommons.org/licenses/by-nc/2.5</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="ddr384.pdf"/><abstract><p>Coronary artery disease (CAD) is the leading cause of death worldwide. Affected individuals cluster in families in patterns that reflect the sharing of numerous susceptibility genes. Genome-wide and large-scale gene-centric genotyping studies that involve tens of thousands of cases and controls have now mapped common disease variants to 34 distinct loci. Some coronary disease common variants show allelic heterogeneity or copy number variation. Some of the loci include candidate genes that imply conventional or emerging risk factor-mediated mechanisms of disease pathogenesis. Quantitative trait loci associations with risk factors have been informative in Mendelian randomization studies as well as fine-mapping of causative variants. But, for most loci, plausible mechanistic links are uncertain or obscure at present but provide potentially novel directions for research into this disease's pathogenesis. The common variants explain &#x0223c;4% of inter-individual variation in disease risk and no more than 13% of the total heritability of coronary disease. Although many CAD genes are presently undiscovered, it is likely that larger collaborative genome-wide association studies will map further common/low-penetrance variants and hoped that low-frequency or rare high-penetrance variants will also be identified in medical resequencing experiments.</p></abstract></article-meta></front><body><sec sec-type="" id="s1"><title>INTRODUCTION</title><p>Coronary artery disease (CAD) is the most frequent cause of death in high-income countries and the second most common cause of death in medium and low-income countries (<xref ref-type="bibr" rid="DDR384C1">1</xref>). It most commonly presents clinically in cases of angina pectoris and myocardial infarction (heart attack), which are due to atherosclerotic plaques that develop progressively as we age and occasionally rupture. Genetic epidemiological studies of family history and twin concordance studies are consistent with an underlying multifactorial model of disease susceptibility with a significant polygenic component. This is complemented by genetic analysis of heritable conventional risk factors such as low-density lipoprotein (LDL)-cholesterol and systolic blood pressure, which collectively might explain a minor portion of coronary disease risk (<xref ref-type="bibr" rid="DDR384C2">2</xref>).</p><p>Over the past 4 years, researchers have completed several genome-wide association studies (GWASs) to map underlying common susceptibility variants for coronary disease. In parallel with GWASs of other complex diseases, it was soon apparent that typical effect sizes for individual single-nucleotide polymorphisms (SNPs) were fairly small, so large sample sizes would be required for reliable gene mapping. This has encouraged collaboration between individual research groups and led to the formation of consortia to pool the results of GWASs using meta-analysis techniques. Progress has been facilitated by the availability of phased haplotype training sets (notably, from the HapMap project: <uri xlink:type="simple" xlink:href="http://hapmap.ncbi.nlm.nih.gov/downloads/phasing">http://hapmap.ncbi.nlm.nih.gov/downloads/phasing</uri>) and the accompanying genotype imputation software (for example, MACH: <uri xlink:type="simple" xlink:href="www.sph.umich.edu/csg/abecasis/MACH/index.html">www.sph.umich.edu/csg/abecasis/MACH/index.html</uri> or IMPUTE: <uri xlink:type="simple" xlink:href="mathgen.stats.ox.ac.uk/impute/impute_v2.html">mathgen.stats.ox.ac.uk/impute/impute_v2.html</uri>). These population genetic resources and statistical genetic tools provide an efficient solution to the fact that individual GWASs are often carried out on different SNP arrays with variable SNP overlap.</p><p>All this effort came to a crescendo this year with the publication of two papers from the CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>) and C4D (<xref ref-type="bibr" rid="DDR384C4">4</xref>) consortia that together scanned nearly 40K coronary disease cases for susceptibility gene signals. Combined with the results from other recent large-scale studies (<xref ref-type="bibr" rid="DDR384C5">5</xref>&#x02013;<xref ref-type="bibr" rid="DDR384C7">7</xref>), 35 common coronary disease variants have been robustly mapped by GWASs (<xref ref-type="bibr" rid="DDR384C3">3</xref>&#x02013;<xref ref-type="bibr" rid="DDR384C7">7</xref>) or gene-centric SNP arrays (<xref ref-type="bibr" rid="DDR384C8">8</xref>) (Table&#x000a0;<xref ref-type="table" rid="DDR384TB1">1</xref>). These results are mostly based on cases and controls of European descent. The C4D (<xref ref-type="bibr" rid="DDR384C4">4</xref>) and gene-centric (<xref ref-type="bibr" rid="DDR384C8">8</xref>) discovery experiments included South Asians from Pakistan and India as well as Europeans; these designs were optimally powered to detect variants that were common to both ancestry groups. Wang <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C7">7</xref>) carried out their GWAS discovery and replication experiments in the Chinese Han population.
<table-wrap id="DDR384TB1" position="float"><label>Table&#x000a0;1.</label><caption><p>Thirty-five common susceptibility variants for coronary artery disease</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Chr</th><th align="left" rowspan="2" colspan="1">Position</th><th align="left" rowspan="2" colspan="1">Locus<sup>a</sup></th><th align="left" rowspan="2" colspan="1">SNP</th><th align="left" rowspan="2" colspan="1">References</th><th align="left" colspan="2" rowspan="1">Reported effect<hr/></th><th align="left" colspan="3" rowspan="1">SNP-specific heritability (<inline-formula><inline-graphic xlink:href="ddr384ileq1.jpg"/></inline-formula>), %</th></tr><tr><th align="left" rowspan="1" colspan="1">EAF</th><th align="left" rowspan="1" colspan="1">OR</th><th align="left" rowspan="1" colspan="1"><italic>K</italic><sub>p</sub>= 2%</th><th align="left" rowspan="1" colspan="1"><italic>K</italic><sub>p</sub>= 5%</th><th align="left" rowspan="1" colspan="1"><italic>K</italic><sub>p</sub>= 10%</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">55 496 039</td><td rowspan="1" colspan="1">PCSK9</td><td rowspan="1" colspan="1">rs11206510</td><td rowspan="1" colspan="1">MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.82</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">56 962 821</td><td rowspan="1" colspan="1">PPAP2B</td><td rowspan="1" colspan="1">rs17114036</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.91</td><td rowspan="1" colspan="1">1.17</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.11</td></tr><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">109 822 166</td><td rowspan="1" colspan="1">SORT1</td><td rowspan="1" colspan="1">rs599839</td><td rowspan="1" colspan="1">Samani <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C58">58</xref>), MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.78</td><td rowspan="1" colspan="1">1.11</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1">0.10</td></tr><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">222 823 529</td><td rowspan="1" colspan="1">MIA3</td><td rowspan="1" colspan="1">rs17465637</td><td rowspan="1" colspan="1">Samani <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C58">58</xref>), MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.74</td><td rowspan="1" colspan="1">1.14</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">44 072 576</td><td rowspan="1" colspan="1">ABCG8</td><td rowspan="1" colspan="1">rs4299376</td><td rowspan="1" colspan="1">HumanCVD (<xref ref-type="bibr" rid="DDR384C8">8</xref>)</td><td rowspan="1" colspan="1">0.29</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">203 745 885</td><td rowspan="1" colspan="1">WDR12</td><td rowspan="1" colspan="1">rs6725887</td><td rowspan="1" colspan="1">MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1">1.14</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.11</td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">138 119 952</td><td rowspan="1" colspan="1">MRAS</td><td rowspan="1" colspan="1">rs2306374</td><td rowspan="1" colspan="1">Erdmann <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C59">59</xref>)</td><td rowspan="1" colspan="1">0.18</td><td rowspan="1" colspan="1">1.12</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">131 867 702</td><td rowspan="1" colspan="1">IL5</td><td rowspan="1" colspan="1">rs2706399</td><td rowspan="1" colspan="1">HumanCVD (<xref ref-type="bibr" rid="DDR384C8">8</xref>)</td><td rowspan="1" colspan="1">0.48</td><td rowspan="1" colspan="1">1.02</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">11 774 583</td><td rowspan="1" colspan="1">C6orf105</td><td rowspan="1" colspan="1">rs6903956<sup>b</sup></td><td rowspan="1" colspan="1">Wang <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C7">7</xref>)</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">1.51</td><td rowspan="1" colspan="1">0.35</td><td rowspan="1" colspan="1">0.45</td><td rowspan="1" colspan="1">0.56</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">12 927 544</td><td rowspan="1" colspan="1">PHACTR1</td><td rowspan="1" colspan="1">rs12526453</td><td rowspan="1" colspan="1">MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.67</td><td rowspan="1" colspan="1">1.10</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1">0.10</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">35 034 800</td><td rowspan="1" colspan="1">ANKS1A</td><td rowspan="1" colspan="1">rs17609940</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">134 214 525</td><td rowspan="1" colspan="1">TCF21</td><td rowspan="1" colspan="1">rs12190287</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.62</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">160 961 137</td><td rowspan="1" colspan="1">LPA</td><td rowspan="1" colspan="1">rs3798220</td><td rowspan="1" colspan="1">Clarke <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C30">30</xref>)</td><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">1.92</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">0.32</td><td rowspan="1" colspan="1">0.40</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">161 010 118</td><td rowspan="1" colspan="1">LPA</td><td rowspan="1" colspan="1">rs10455872</td><td rowspan="1" colspan="1">Clarke <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C30">30</xref>)</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">1.70</td><td rowspan="1" colspan="1">0.57</td><td rowspan="1" colspan="1">0.73</td><td rowspan="1" colspan="1">0.90</td></tr><tr><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">107 244 545</td><td rowspan="1" colspan="1">7q22</td><td rowspan="1" colspan="1">rs10953541</td><td rowspan="1" colspan="1">C4D 2011 (<xref ref-type="bibr" rid="DDR384C4">4</xref>)</td><td rowspan="1" colspan="1">0.80</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">129 663 496</td><td rowspan="1" colspan="1">ZC3HC1</td><td rowspan="1" colspan="1">rs11556924</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.62</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">126 495 818</td><td rowspan="1" colspan="1">TRIB1</td><td rowspan="1" colspan="1">rs10808546</td><td rowspan="1" colspan="1">HumanCVD (<xref ref-type="bibr" rid="DDR384C8">8</xref>)</td><td rowspan="1" colspan="1">0.65</td><td rowspan="1" colspan="1">1.04</td><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1">0.02</td></tr><tr><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">22 098 574</td><td rowspan="1" colspan="1">ANRIL/CDKN2BAS</td><td rowspan="1" colspan="1">rs4977574</td><td rowspan="1" colspan="1">WTCCC (<xref ref-type="bibr" rid="DDR384C60">60</xref>), McPherson <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C61">61</xref>), Helgadottir <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C62">62</xref>), Samani <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C58">58</xref>), MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.46</td><td rowspan="1" colspan="1">1.29</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">0.68</td><td rowspan="1" colspan="1">0.84</td></tr><tr><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">136 154 168</td><td rowspan="1" colspan="1">ABO</td><td rowspan="1" colspan="1">rs579459</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>), Reilly <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C6">6</xref>)</td><td rowspan="1" colspan="1">0.21</td><td rowspan="1" colspan="1">1.10</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">30 335 122</td><td rowspan="1" colspan="1">KIAA1462</td><td rowspan="1" colspan="1">rs2505083</td><td rowspan="1" colspan="1">C4D 2011 (<xref ref-type="bibr" rid="DDR384C4">4</xref>), Erdmann <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C5">5</xref>)</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">44 775 824</td><td rowspan="1" colspan="1">CXCL12</td><td rowspan="1" colspan="1">rs1746048</td><td rowspan="1" colspan="1">Samani <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C58">58</xref>), MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.87</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.04</td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">91 002 927</td><td rowspan="1" colspan="1">LIPA</td><td rowspan="1" colspan="1">rs1412444</td><td rowspan="1" colspan="1">C4D 2011 (<xref ref-type="bibr" rid="DDR384C4">4</xref>)</td><td rowspan="1" colspan="1">0.42</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">104 719 096</td><td rowspan="1" colspan="1">CYP17A1-NT5C2</td><td rowspan="1" colspan="1">rs12413409</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.89</td><td rowspan="1" colspan="1">1.12</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">103 660 567</td><td rowspan="1" colspan="1">PDGFD</td><td rowspan="1" colspan="1">rs974819</td><td rowspan="1" colspan="1">C4D 2011 (<xref ref-type="bibr" rid="DDR384C4">4</xref>)</td><td rowspan="1" colspan="1">0.32</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">116 648 917</td><td rowspan="1" colspan="1">APOA1-C3-A4-A5</td><td rowspan="1" colspan="1">rs964184</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1">1.13</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">111 884 608</td><td rowspan="1" colspan="1">SH2B3</td><td rowspan="1" colspan="1">rs3184504</td><td rowspan="1" colspan="1">Soranzo <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C63">63</xref>)</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">110 960 712</td><td rowspan="1" colspan="1">COL4A1-A2</td><td rowspan="1" colspan="1">rs4773144</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">100 133 942</td><td rowspan="1" colspan="1">HHIPL1</td><td rowspan="1" colspan="1">rs2895811</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.43</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">79 111 093</td><td rowspan="1" colspan="1">ADAMTS7</td><td rowspan="1" colspan="1">rs4380028</td><td rowspan="1" colspan="1">C4D 2011 (<xref ref-type="bibr" rid="DDR384C4">4</xref>), CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>), Reilly <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C6">6</xref>)</td><td rowspan="1" colspan="1">0.60</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">2 126 504</td><td rowspan="1" colspan="1">SMG6-SRR</td><td rowspan="1" colspan="1">rs216172</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.37</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">17 543 722</td><td rowspan="1" colspan="1">PEMT</td><td rowspan="1" colspan="1">rs12936587</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.56</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">46 988 597</td><td rowspan="1" colspan="1">GIP-ATP</td><td rowspan="1" colspan="1">rs46522</td><td rowspan="1" colspan="1">CARDIoGRAM (<xref ref-type="bibr" rid="DDR384C3">3</xref>)</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">1.06</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1">0.04</td></tr><tr><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">11 163 601</td><td rowspan="1" colspan="1">LDLR</td><td rowspan="1" colspan="1">rs1122608</td><td rowspan="1" colspan="1">MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.77</td><td rowspan="1" colspan="1">1.14</td><td rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1">0.12</td><td rowspan="1" colspan="1">0.15</td></tr><tr><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">45 395 619</td><td rowspan="1" colspan="1">APOE</td><td rowspan="1" colspan="1">rs2075650</td><td rowspan="1" colspan="1">HumanCVD (<xref ref-type="bibr" rid="DDR384C8">8</xref>)</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">1.14</td><td rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.11</td></tr><tr><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">35 599 128</td><td rowspan="1" colspan="1">MRPS6</td><td rowspan="1" colspan="1">rs9982601</td><td rowspan="1" colspan="1">MIGen (<xref ref-type="bibr" rid="DDR384C36">36</xref>)</td><td rowspan="1" colspan="1">0.15</td><td rowspan="1" colspan="1">1.18</td><td rowspan="1" colspan="1">0.11</td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">0.18</td></tr><tr><td colspan="7" rowspan="1"><inline-formula><inline-graphic xlink:href="ddr384ileq2.jpg"/></inline-formula></td><td rowspan="1" colspan="1"><bold>3.30</bold></td><td rowspan="1" colspan="1"><bold>4.27</bold></td><td rowspan="1" colspan="1"><bold>5.29</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Chr, chromosome; Position, position (in bp) on GRCh37/hg19 (Genome Reference Consortium February 2009); EAF, effect allele frequency; OR, odds ratio; <inline-formula><inline-graphic xlink:href="ddr384ileq3.jpg"/></inline-formula>, SNP-specific heritability estimates are shown for three disease prevalence estimates; <italic>K</italic><sub>p,</sub> disease prevalence estimate for SNP-specific heritability estimate; <inline-formula><inline-graphic xlink:href="ddr384ileq4.jpg"/></inline-formula> total SNP-encoded heritability for each disease prevalence estimate are shown in bold type.</p></fn><fn><p><sup>a</sup>Most locus assignments are provisional based on proximity (see text).<sup>b</sup>Effect allele frequency and odds ratio are given for Chinese Han population.</p></fn></table-wrap-foot></table-wrap></p><p>For some of the SNPs, there is circumstantial evidence to highlight an underlying gene. For example, <italic>LIPA</italic> encodes lipase A, which catalyzes the hydrolysis of cholesteryl esters and triglycerides. The lead CAD risk SNP in <italic>LIPA</italic> (<xref ref-type="bibr" rid="DDR384C4">4</xref>,<xref ref-type="bibr" rid="DDR384C8">8</xref>) is strongly correlated with expression quantitative trait loci (eQTL) SNP, with the CAD risk allele correlated with increased expression of <italic>LIPA</italic> mRNA in monocytes (<xref ref-type="bibr" rid="DDR384C9">9</xref>) and liver (<xref ref-type="bibr" rid="DDR384C4">4</xref>), suggesting a functional relationship between the disease association signal and this candidate gene. However, for most of the SNPs mapped by GWASs, it is difficult to implicate an underlying gene. Inspection of recombination frequency maps derived from the HapMap project suggest genetic boundaries defined by recombination hotspots, which drives the traditional approach of fine-mapping using haplotype block information (<xref ref-type="bibr" rid="DDR384C10">10</xref>). However, there is ample evidence that <italic>cis</italic>-regulatory mechanisms in the <italic>soma</italic> can operate over tens, hundreds or even millions of base pairs and are presumably unaffected by meiotic recombination (<xref ref-type="bibr" rid="DDR384C11">11</xref>). It is becoming possible to define functional genomic boundaries based on chromatin architecture-related factors, such as CCCTC-binding factor sites (<xref ref-type="bibr" rid="DDR384C12">12</xref>) that are found in the vast majority of vertebrate insulator elements. We suspect that, for most coronary disease loci, it will take some time to complete the sequence of functional genomics experiments that will be required to confidently lay the blame of disease susceptibility on a specific underlying gene. The loci shown in Table&#x000a0;<xref ref-type="table" rid="DDR384TB1">1</xref> should therefore be interpreted as provisional assignments based mainly on proximity (nearest coding sequence).</p><p>It is noteworthy that the lists of confidently assigned genes across the recent crop of studies show little overlap, which at first glance seems unlikely to be due to differences in tagging SNP coverage, phenotypic heterogeneity or ancestry (these studies are heavily weighted towards European ancestry). We suspect that it most likely has its roots in the small effects conferred by the susceptibility genes (each allele increases risk by &#x0223c;5%). Such small gene effects would, in a GWAS discovery experiment comprising 20K cases and 20K controls, be expected to have only a 5% probability of passing even a modest stage-1 (tentative discovery) threshold of <italic>P</italic>&#x0003c; 0.00001. Therefore, in absolute terms, this low power to detect an individual gene means that different, and only occasionally overlapping, sets of susceptibility loci are likely to emerge from similarly sized studies (<xref ref-type="bibr" rid="DDR384C13">13</xref>,<xref ref-type="bibr" rid="DDR384C14">14</xref>). Of course, even for loci that have surpassed the <italic>de facto</italic> genome-wide significance threshold of 5 &#x000d7; 10<sup>&#x02212;8</sup>, there is still an appreciable chance that one or more of the 34 loci will prove to be false-positives (<xref ref-type="bibr" rid="DDR384C15">15</xref>). We expect based on binomial theory that the maximum number of false-positive associations in Table&#x000a0;<xref ref-type="table" rid="DDR384TB1">1</xref> will be three or fewer. Skol <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C16">16</xref>) pointed out that a combined analysis of stage 1 discovery data (based on GWAS SNP arrays) and stage 2 validation data (a subset of the most promising SNPs from stage 1) is more efficient than attempting formal replication in stage 2 and such an analysis is now standard practise. However, some researchers, mindful of historical difficulties of interpreting complex genetic data (<xref ref-type="bibr" rid="DDR384C17">17</xref>), prefer to apply a cautious approach to secure robust (i.e. taking into account stage 2 multiple testing penalties) and independent (of GWAS discovery) replication data (<xref ref-type="bibr" rid="DDR384C3">3</xref>,<xref ref-type="bibr" rid="DDR384C4">4</xref>).</p><p>GWAS is a &#x02018;hypothesis-free&#x02019; approach to the study of complex diseases, which depends on mutations that unpredictably occurred in previous generations, and purely by chance (genetic drift) or by (balancing) selection is now common. As such the loci that are identified provide a framework for what we know and do not know about pathogenesis from other hypothesis-led (e.g. physiological, biochemical or cell biological) experiments. In the case of coronary disease genetics, we have examples that illustrate complex genetic architectural features such as allelic heterogeneity, pleiotropy, risk factor QTLs, copy number variation (CNV) or synthetic associations, which are discussed below. There are findings that could lead to tangible clinical benefits relatively soon (<italic>LPA</italic> and <italic>SORT1</italic>). But mainly there are leads to point researchers in unanticipated directions, at least some of which we hope will provide novel biological insights into how atherosclerotic plaques develop and rupture.</p></sec><sec id="s2"><title>HOW MUCH HERITABILITY HAS BEEN MAPPED?</title><p>Manolio <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C18">18</xref>) have pointed out that despite the success of GWAS in mapping common susceptibility variants for many multifactorial diseases, collectively these variants typically explain a modest fraction of the total heritability of these conditions. The accuracy of such calculations depends on the fidelity of a series of locus-specific heritability estimates as well as the total (i.e. measured plus unmeasured) heritability.</p><p>Locus-specific heritability estimates are based on odds ratio estimates that assume that the lead SNP at a locus accurately tags the disease-causing variant. No correction is usually made for potential biases due to the &#x02018;winner&#x02019;s curse&#x02019; (<xref ref-type="bibr" rid="DDR384C19">19</xref>) or to signal attenuation due to clinically unscreened control data (<xref ref-type="bibr" rid="DDR384C20">20</xref>). External (to the case&#x02013;control data) epidemiological information on disease prevalence is required if the multifactorial threshold model is to be used to calculate locus-specific heritabilities. Prevalence estimates can vary substantially with clinical phenotype, sex, and age and are drifting over time with changing environmental risk factor exposures (<uri xlink:type="simple" xlink:href="www.heartstats.org">www.heartstats.org</uri>); we suggest that a range of prevalences between 2 and 10% is relevant to coronary disease GWAS case series.</p><p>Invaluable coronary disease heritability data are derived from the longitudinal study of over 20K twins in the Swedish Twin Registry (Karolinska Institute, Stockholm, Sweden). The total heritability of coronary disease was estimated for angina in men as 39% (95% CI 29&#x02013;49%) and in women as 43% (8&#x02013;51%) (<xref ref-type="bibr" rid="DDR384C21">21</xref>) and for death from coronary disease in men as 57% (45&#x02013;69%) and in women as 38% (26&#x02013;50%) (<xref ref-type="bibr" rid="DDR384C22">22</xref>). Genetic association studies generally use samples collected from survivors of disease, for ethical and other pragmatic reasons. For coronary disease, case series are clinically heterogeneous if they include different diagnostic subgroups (e.g. chronic stable angina or myocardial infarction) with subtly differing pathologies that might have an impact on susceptibility. So, we propose that a heritability estimate of 40% will encompass the clinical heterogeneity across typical GWAS case series.</p><p>Taking all of these issues into account, we estimate that between 8 and 13% of the total heritability of coronary disease can be explained by the 35 common variants (Table&#x000a0;<xref ref-type="table" rid="DDR384TB1">1</xref>). So, the vast majority of the heritability is currently unexplained. X-linked single-gene disorders have intrinsic advantages for gene mapping, so it is a pity that the X-chromosome has sometimes been overlooked in the search for coronary disease susceptibility loci (contrast the CARDiOGRAM study which was based on imputed data with C4D which was based solely on genotype data). This can easily be resolved as appropriate analytic means (i.e. phased haplotype training sets and imputation software) are now freely available and have proved productive in the investigation of the X chromosome in other disease areas [e.g. type 2 diabetes (<xref ref-type="bibr" rid="DDR384C23">23</xref>)].</p><p>Although there was little evidence for non-additive genetic effects in the aforementioned twin studies of coronary disease, we note that classic MZ/DZ concordance studies have very limited power to identify non-additive variance components (<xref ref-type="bibr" rid="DDR384C24">24</xref>). Moreover, dominance and epistatic variance components are inevitably confounded in this design (<xref ref-type="bibr" rid="DDR384C25">25</xref>). Consequently, there seems no reason why epistatic and high-penetrance/low-frequency alleles should not explain a portion of the missing heritability. Indeed, some of the linkages detected in earlier affected-sib-pair studies (<xref ref-type="bibr" rid="DDR384C26">26</xref>,<xref ref-type="bibr" rid="DDR384C27">27</xref>) might be conferred by low-frequency alleles with or without allelic heterogeneity. For example, the locus on chromosome 17p reported by PROCARDIS (<xref ref-type="bibr" rid="DDR384C27">27</xref>) was associated with a sibling recurrence risk ratio (&#x003bb;<sub>sib</sub>) of 1.29 that could theoretically be conferred by a dominant, low-frequency (0.5%) allele of intermediate penetrance (17.2%) and with a 1.8% phenocopy rate. Such linkage signals are usually intractable to conventional GWAS based on common SNPs (<xref ref-type="bibr" rid="DDR384C28">28</xref>) but might be resolved by means of resequencing-based analyses or genotyping arrays with good coverage of low-frequency variants.</p></sec><sec id="s3"><title>SUSCEPTIBILITY ENCODED BY CNV</title><p>The development of array-based methods to systematically study CNV has allowed researchers to study the role of this rich source of genetic variation in common multifactorial diseases (<xref ref-type="bibr" rid="DDR384C29">29</xref>). It is ironic that these high-throughput techniques with genome-wide coverage of CNVs have overlooked an exemplar of common disease susceptibility namely that encoded by the apolipoprotein(a) (<italic>LPA</italic>) gene. This gene includes a highly variable number of kringle IV-2 repeats (range at least 12&#x02013;44) which result in numerous isoforms that can be typed by protein electrophoresis (<xref ref-type="bibr" rid="DDR384C30">30</xref>) or genomically quantified by qPCR (<xref ref-type="bibr" rid="DDR384C30">30</xref>&#x02013;<xref ref-type="bibr" rid="DDR384C32">32</xref>). Two SNPs that tag short isoform alleles that are encoded by relatively low copy numbers of kringle IV-2 sequences show strong associations with high lipoprotein(a) levels and with coronary disease risk (OR= &#x0223c;1.5) (<xref ref-type="bibr" rid="DDR384C30">30</xref>). These SNPs were not included on commonly used GWAS SNP arrays (but were fortuitously included in the design of the HumanCVD gene-centric SNP array) and have been recalcitrant to genotype imputation due to their frequency or linkage disequilibrium properties. Consequently, they have not been assessed in GWAS meta-analyses of coronary disease susceptibility.</p></sec><sec id="s4"><title>ALLELIC HETEROGENEITY AND PLEIOTROPY</title><p>Allelic heterogeneity is a regular feature of complex diseases and traits. For example, multiple independent signals were detected at 19 of 180 height QTL (<xref ref-type="bibr" rid="DDR384C33">33</xref>). Researchers have systematically scanned for secondary association signals of coronary disease (by conditioning on the lead SNP at each locus), an approach that identified multiple independent SNP signals in <italic>LPA</italic> (<xref ref-type="bibr" rid="DDR384C30">30</xref>). The coronary disease associations in <italic>PCKS9</italic> detected by the non-synonymous R46L SNP rs11591147 (<xref ref-type="bibr" rid="DDR384C34">34</xref>,<xref ref-type="bibr" rid="DDR384C35">35</xref>) and a non-coding SNP rs11206510 (<xref ref-type="bibr" rid="DDR384C36">36</xref>) appear to be independent as the two SNPs show little linkage disequilibrium (<italic>r</italic><sup>2</sup>= 0.04 in PROCARDIS Human CVD data). A possible example of allelic heterogeneity arises for SNPs rs3825807 (<xref ref-type="bibr" rid="DDR384C3">3</xref>) and rs1994016 (<xref ref-type="bibr" rid="DDR384C6">6</xref>) that map to alternate flanks of the <italic>ADAMTS7</italic> gene on chromosome 15 to rs4380028 (<xref ref-type="bibr" rid="DDR384C4">4</xref>) and are in moderate linkage disequilibrium (<italic>r</italic><sup>2</sup>= &#x0223c;0.50).</p><p>Coronary disease shows substantial clinical heterogeneity that is reflected in morphological differences in the atherosclerotic plaques (<xref ref-type="bibr" rid="DDR384C37">37</xref>) that might in turn reflect differences in inherited susceptibilities. Plaque rupture and subsequent coronary thrombosis causes acute coronary syndromes such as myocardial infarction, thereby motivating searches for genes that might influence plaque stability. Reilly <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C6">6</xref>) undertook a GWAS of coronary disease patients with angiographic disease contrasting those cases that had suffered myocardial infarction with those who had not. This study mapped a novel association to the ABO blood group system with SNPs that strongly tag the O allele. The CARDIoGRAM consortium (<xref ref-type="bibr" rid="DDR384C3">3</xref>), which studied a mixture of coronary disease cases of which two-thirds had suffered a myocardial infarction and a mixture of screened and unscreened controls, also mapped a susceptibility signal to the ABO system. Their lead SNP is only in moderate linkage disequilibrium (<italic>r</italic><sup>2</sup>= 0.39) with the Reilly <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C6">6</xref>) signal so may be due to allelic heterogeneity or pleiotropy. We must await further fine-mapping studies of the <italic>ABO</italic> and <italic>ADAMTS7</italic> loci to fully understand the details of these associations.</p></sec><sec id="s5"><title>QTL MAPPING AND CONVENTIONAL RISK FACTORS</title><p>Conventional risk factors for coronary disease such as circulating lipid levels and blood pressure are heritable (quantitative) traits. There has been much effort in mapping common QTL for these traits using GWAS or other large-scale SNP arrays in population-based as well as case&#x02013;control samples (<xref ref-type="bibr" rid="DDR384C38">38</xref>&#x02013;<xref ref-type="bibr" rid="DDR384C40">40</xref>). Technical difficulties such as uncontrolled fasting status or on-treatment measurements have been largely overcome to produce a rich crop of risk factor QTL. Notable examples of overlap with coronary disease loci (Table&#x000a0;<xref ref-type="table" rid="DDR384TB2">2</xref>) include <italic>TRIB1</italic> (<italic>Drosophila</italic> tribbles homologue, a gene that interacts with the mitogen-activated protein kinase cascade), which has pleiotropic effects on circulating triglyceride, LDL- and HDL-cholesterol levels (<xref ref-type="bibr" rid="DDR384C40">40</xref>) and <italic>CYP17A1</italic> (17-&#x003b1; hydroxylase gene involved in steroid hormone metabolism) which is a systolic blood pressure QTL (<xref ref-type="bibr" rid="DDR384C38">38</xref>,<xref ref-type="bibr" rid="DDR384C39">39</xref>). However, most (22 of 34) of the coronary disease loci do not show convincing risk factor QTL effects (Table&#x000a0;<xref ref-type="table" rid="DDR384TB2">2</xref>). It may be that novel heritable intermediate phenotypes will eventually be identified that will explain some of the disease associations; this should lead to informative insights into pathological mechanisms. Indeed, expectations that coronary genes would be involved in innate immunity or thrombosis have not emerged from large-scale genetic association studies to date.
<table-wrap id="DDR384TB2" position="float"><label>Table&#x000a0;2.</label><caption><p>Risk factor QTL and coronary artery disease</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Locus<sup>a</sup></th><th align="left" rowspan="1" colspan="1">QTL</th><th align="left" rowspan="1" colspan="1">Lead QTL SNP</th><th align="left" rowspan="1" colspan="1">CAD Risk SNP</th><th align="left" rowspan="1" colspan="1"><italic>r</italic><sup>2</sup></th><th align="left" rowspan="1" colspan="1">Reference(s)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">PCSK9</td><td rowspan="1" colspan="1">LDL, TC</td><td rowspan="1" colspan="1">rs2479409</td><td rowspan="1" colspan="1">rs11206510</td><td rowspan="1" colspan="1">&#x0003c;0.30</td><td rowspan="1" colspan="1">Kathiresan <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C64">64</xref>), Teslovich <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">PPAP2B</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs17114036</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">SORT1</td><td rowspan="1" colspan="1">LDL, TC</td><td rowspan="1" colspan="1">rs646776</td><td rowspan="1" colspan="1">rs599839</td><td rowspan="1" colspan="1">0.91</td><td rowspan="1" colspan="1">Kathiresan <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C64">64</xref>), Teslovich <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">MIA3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs17465637</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ABCG8</td><td rowspan="1" colspan="1">LDL</td><td rowspan="1" colspan="1">rs4299376</td><td rowspan="1" colspan="1">rs4299376</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">Teslovich <italic>et al.</italic> (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">WDR12</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs6725887</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">MRAS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs2306374</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">IL5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs2706399</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">C6orf105</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs6903956*</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PHACTR1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs12526453</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ANKS1A</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs17609940</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TCF21</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs12190287</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">LPA</td><td rowspan="1" colspan="1">Lp(a)</td><td rowspan="1" colspan="1">rs10455872</td><td rowspan="1" colspan="1">rs10455872</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">Clarke <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C30">30</xref>)</td></tr><tr><td rowspan="1" colspan="1">LPA</td><td rowspan="1" colspan="1">Lp(a)</td><td rowspan="1" colspan="1">rs3798220</td><td rowspan="1" colspan="1">rs3798220</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">Clarke <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C30">30</xref>)</td></tr><tr><td rowspan="1" colspan="1">LPA</td><td rowspan="1" colspan="1">LDL, TC</td><td rowspan="1" colspan="1">rs1564348</td><td rowspan="1" colspan="1">rs10455872</td><td rowspan="1" colspan="1">&#x0003c;0.30</td><td rowspan="1" colspan="1">Teslovich <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">LPA</td><td rowspan="1" colspan="1">HDL</td><td rowspan="1" colspan="1">rs1084651</td><td rowspan="1" colspan="1">rs10455872</td><td rowspan="1" colspan="1">NA<sup>b</sup></td><td rowspan="1" colspan="1">Teslovich <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">7q22</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs10953541</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ZC3HC1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs11556924</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TRIB1</td><td rowspan="1" colspan="1">TG, TC, LDL, HDL</td><td rowspan="1" colspan="1">rs2954029</td><td rowspan="1" colspan="1">rs10808546</td><td rowspan="1" colspan="1">0.96</td><td rowspan="1" colspan="1">Kathiresan <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C64">64</xref>), Teslovich <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">ANRIL/CDKN2BAS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs4977574</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ABO</td><td rowspan="1" colspan="1">LDL, TC</td><td rowspan="1" colspan="1">rs9411489</td><td rowspan="1" colspan="1">rs579459</td><td rowspan="1" colspan="1">&#x0003c;0.30</td><td rowspan="1" colspan="1">Teslovich <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">KIAA1462</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs2505083</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CXCL12</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs1746048</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">LIPA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs1412444</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">CYP17A1-NT5C2</td><td rowspan="1" colspan="1">blood pressure</td><td rowspan="1" colspan="1">rs11191548</td><td rowspan="1" colspan="1">rs12413409</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">Newton-Cheh <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C38">38</xref>)</td></tr><tr><td rowspan="1" colspan="1">PDGFD</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs974819</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">APOA1-C3-A4-A5</td><td rowspan="1" colspan="1">TG, HDL</td><td rowspan="1" colspan="1">rs964184</td><td rowspan="1" colspan="1">rs964184</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">Kathiresan <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C64">64</xref>), Teslovich <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">SH2B3</td><td rowspan="1" colspan="1">blood pressure</td><td rowspan="1" colspan="1">rs3184504</td><td rowspan="1" colspan="1">rs3184504</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">Levy <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C39">39</xref>)</td></tr><tr><td rowspan="1" colspan="1">COL4A1-A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs4773144</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HHIPL1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs2895811</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ADAMTS7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs4380028</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">SMG6-SRR</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs216172</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PEMT</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs12936587</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">GIP-ATP</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs46522</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">LDLR</td><td rowspan="1" colspan="1">LDL, TC</td><td rowspan="1" colspan="1">rs6511720</td><td rowspan="1" colspan="1">rs1122608</td><td rowspan="1" colspan="1">&#x0003c;0.30</td><td rowspan="1" colspan="1">Teslovich <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">APOE</td><td rowspan="1" colspan="1">LDL, TC, HDL</td><td rowspan="1" colspan="1">rs4420638</td><td rowspan="1" colspan="1">rs2075650</td><td rowspan="1" colspan="1">0.40</td><td rowspan="1" colspan="1">Kathiresan <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C64">64</xref>), Teslovich <italic>et al</italic>. (<xref ref-type="bibr" rid="DDR384C40">40</xref>)</td></tr><tr><td rowspan="1" colspan="1">MRPS6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">rs9982601</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p><italic>r</italic><sup>2</sup>, measure of linkage disequilibrium between the lead QTL SNP and the lead risk SNP; LDL, LDL-cholesterol; HDL, HDL-cholesterol; TC, total cholesterol; TG, triglycerides.</p></fn><fn><p><sup>a</sup>Most locus assignments are provisional based on proximity (see text).</p></fn><fn><p><sup>b</sup>SNP rs1084651 had a &#x0003e;5% genotyping failure rate in the HapMap database Rel23.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s6"><title>MOVING FROM ASSOCIATED LOCUS TO CAUSATIVE GENE</title><p>Robust assignments of common susceptibility variants are to be applauded, but it may take some time to resolve the underlying molecular genetic mechanisms. For instance, the first coronary disease locus to confidently emerge from GWAS mapped to chromosome 9p21 to a region that was initially believed to be a gene desert. However, it was quickly recognized in fine-mapping studies (<xref ref-type="bibr" rid="DDR384C10">10</xref>) that the associated region, which was of prior interest to cancer genetics researchers (<xref ref-type="bibr" rid="DDR384C41">41</xref>,<xref ref-type="bibr" rid="DDR384C42">42</xref>), was potentially linked to neighbouring cyclin-dependent kinase inhibitor genes <italic>CDKN2A</italic> (which has multiple synonyms including p16, see <uri xlink:type="simple" xlink:href="www.genecards.org/cgi-bin/carddisp.pl?gene=CDKN2A">www.genecards.org/cgi-bin/carddisp.pl?gene=CDKN2A</uri> for more details) and <italic>CDKN2B</italic> (p15, see <uri xlink:type="simple" xlink:href="www.genecards.org/cgi-bin/carddisp.pl?gene=CDKN2B">www.genecards.org/cgi-bin/carddisp.pl?gene=CDKN2B</uri>). Subsequent studies of murine models have highlighted a Cdkn2a/b-mediated mechanism involving smooth muscle cell proliferation (<xref ref-type="bibr" rid="DDR384C43">43</xref>). Studies of human transcription enhancer elements propose that the large non-coding antisense RNA molecule <italic>CDKN2ABAS</italic>, which is also known by the monikers <italic>ANRIL</italic> and <italic>CDKN2B-AS1</italic>, is involved in the long-range transcriptional regulation of several genes, including <italic>CDKN2A</italic> and <italic>CDKN2B</italic>, in vascular endothelial cell lines (<xref ref-type="bibr" rid="DDR384C44">44</xref>).</p><p>Another notable success story followed the overlap of LDL-cholesterol QTL and coronary disease association signals on chromosome 1p. Here eQTL were particularly informative to resolve the role of <italic>SORT1</italic> which encodes sortilin from it's neighbours (<xref ref-type="bibr" rid="DDR384C45">45</xref>). Parallel functional studies have implicated sortilin as a novel regulator of lipoprotein production in the liver (<xref ref-type="bibr" rid="DDR384C46">46</xref>), thereby providing a mechanistic link to the coronary disease susceptibility although some details of the mechanism need to be reconciled.</p></sec><sec id="s7"><title>DISCREPANCIES BETWEEN MEASURED AND PREDICTED GENETIC RISK</title><p>Using results from proxy SNPs that are in almost complete linkage disequilibrium with each other, the CARDIoGRAM and C4D studies provide a joint <italic>SORT1</italic> per-allele risk estimate equal to 1.12 (1.09&#x02013;1.15). The measured per-allele QTL effect on LDL-cholesterol is equal to 0.145 mmol/l (0.135&#x02013;0.155) (<xref ref-type="bibr" rid="DDR384C40">40</xref>). Substituting the latter QTL effect into the Framingham coronary heart disease risk equation (<xref ref-type="bibr" rid="DDR384C47">47</xref>) predicts a per-allele relative risk equal to 1.042 (1.039&#x02013;1.045). So, the coronary disease risk estimate derived from GWAS is substantially higher than that predicted from the effect on LDL-cholesterol levels derived from long-term prospective studies.</p><p>A similar discrepancy was noted in a genotype risk score analysis of the Malm&#x000f6; Diet and Cancer study (<xref ref-type="bibr" rid="DDR384C48">48</xref>). Given the underlying sample sizes (&#x0003e;100K for the lipid QTL GWAS experiment) and the consequent precision of the risk factor effect sizes, it seems unlikely that these have been systematically underestimated. It is possible that the disease risk estimates have been overestimated [e.g. winner&#x02019;s curse (<xref ref-type="bibr" rid="DDR384C19">19</xref>)] and/or the disease associations are only partially mediated through the accompanying risk factor QTL effect (i.e. pleiotropy). Moreover, the Framingham risk equations, which were based on US population data from 1970s onwards, were based on single (baseline) cholesterol measurements. Cholesterol measurements are subject to short-term (e.g. variable fasting) as well as long-term variation (e.g. changes in diet). Such within-individual variation can result in the systematic underestimation of the strength of a risk factor association with disease, an epidemiological effect known as regression dilution bias (<xref ref-type="bibr" rid="DDR384C49">49</xref>). Whatever the explanation, these findings emphasize that genetic epidemiological inferences from cross-sectional data need cautious interpretation and that information from prospective studies (e.g. UK BIOBANK, <uri xlink:type="simple" xlink:href="www.ukbiobank.ac.uk">www.ukbiobank.ac.uk</uri>) will be very informative.</p></sec><sec id="s8"><title>GENETIC INSIGHTS FOR EMERGING RISK FACTORS</title><p>Common variants that show quantitative genetic variation for disease risk factors or intermediate phenotypes can probe the putative causal relationship between risk factor and disease. This Mendelian randomization (MR) information (<xref ref-type="bibr" rid="DDR384C50">50</xref>) is particularly useful when there are no drugs that specifically modulate the exposure. For instance, Lp(a) is an LDL particle that appears to be proatherogenic in cross-sectional and prospective epidemiological studies. But drugs such as niacin that reduce Lp(a) concentrations also beneficially increase the HDL levels. So, it can be difficult in randomized clinical trials (RCT) to unambiguously attribute any clinical benefit to specific mechanisms. Following a large-scale candidate gene study, two SNPs in the apolipoprotein(a) gene were shown to tag short isoform alleles that were strikingly associated with raised Lp(a) concentrations and coronary disease risk (<xref ref-type="bibr" rid="DDR384C30">30</xref>) (also discussed in CNV and allelic heterogeneity sections above). Simultaneous modelling of disease risk and quantitative genetic variation were consistent with a direct causal link, thus predicting that pharmacological lowering of Lp(a) levels will be beneficial to patients. Loci that carry triglyceride QTL such as <italic>TRIB1</italic> and <italic>APOA1-C3-A4-A5</italic> also show QTL effects for HDL and LDL. Consequently, these pleiotropic loci will not be useful for MR probing of the role of triglyceride, a well-studied lipid that is presently not routinely included in cardiovascular risk calculations.</p></sec><sec id="s9"><title>CANDIDATE AND POSITIONALLY CLONED GENES</title><p>Before the GWAS epoch, there was much effort expended in scanning candidate genes, those genes with known or predicted functions that might be involved in coronary disease pathogenesis, for susceptibility variants. This research was supplemented by positional cloning experiments that were unbiased in terms of gene candidature (<xref ref-type="bibr" rid="DDR384C51">51</xref>). In comparison with the levels of statistical support required for GWAS, the evidence for most of the candidate genes was modest despite meta-analyses involving up to 36K subjects (<xref ref-type="bibr" rid="DDR384C52">52</xref>). For instance, genetic variation in the apolipoprotein E gene (<italic>APOE</italic>) has well-known effects on LDL-cholesterol and is a highly plausible coronary disease candidate gene. However, a meta-analysis of 17 studies with at least 500 cases that included 21 331 cases and 47 467 controls estimated the risk of carrying the protective &#x0025b;2 allele (versus &#x0025b;3/ &#x0025b;3 homozygotes) as 0.80 (95% CI 0.70&#x02013;0.90) (<xref ref-type="bibr" rid="DDR384C53">53</xref>); the significance of this association is approximately <italic>P</italic>= 0.0005, four orders of magnitude below genome-wide significance. GWAS, even when enhanced by genotype imputation, may not accurately tag specific candidate gene variants [e.g. <italic>LPA</italic> and rs10455872 (<xref ref-type="bibr" rid="DDR384C30">30</xref>)]. So, the absence of a GWAS signal cannot be assumed to negate prior candidate or positional cloned genes (<xref ref-type="bibr" rid="DDR384C8">8</xref>). Indeed, the design of the HumanCVD gene-centric SNP array has revealed several novel loci <italic>LIPA</italic>, <italic>IL5</italic>, <italic>TRIB1</italic> and <italic>ABCG5/ABCG8</italic> as well as finally robustly confirming the candidature of <italic>APOE</italic> (<xref ref-type="bibr" rid="DDR384C8">8</xref>).</p></sec><sec id="s10"><title>FUTURE DIRECTIONS AND PROSPECTS</title><p>Models of the genetic architecture of complex traits (<xref ref-type="bibr" rid="DDR384C33">33</xref>) predict that large numbers of small effect susceptibility loci remain to be discovered, some of which should be tractable to well-powered GWAS. The momentum amongst researchers to meta-analyse GWAS data will be sustained as larger consortia (e.g. the recently merged CARDIoGRAMplusC4D consortium) are formed. They can take full advantage of initiatives such as the Metabochip project, a custom array containing 196 725 SNPs that builds on the CARDIoGRAM stage-1 discovery results. So, it is reasonable to expect that the number of common coronary disease variants will increase, although as each novel variant will be associated with increasingly tiny effects, it seems that the missing heritability gap will never be filled by common variants alone.</p><p>The compilation of an exhaustive list of human genetic variation through the dbSNP (<uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP">http://www.ncbi.nlm.nih.gov/projects/SNP</uri>) and HapMap (<uri xlink:type="simple" xlink:href="http://hapmap.ncbi.nlm.nih.gov/">http://hapmap.ncbi.nlm.nih.gov/</uri>) projects is being systematically expanded by the 1000 Genomes project (<uri xlink:type="simple" xlink:href="http://www.1000genomes.org">http://www.1000genomes.org</uri>). This is particularly useful for low-frequency variants (minimum allele frequency &#x0003c;5%), which were largely absent from the early genome-wide SNPs arrays, which were designed to type common variants in GWAS. Synthetic associations due to tagging of rare variants by common SNPs or haplotypes composed of common SNPs can occasionally be detected (<xref ref-type="bibr" rid="DDR384C54">54</xref>); this is particularly useful if the rare variant might disrupt gene function (e.g. non-synonymous SNP). Consequently, analyses of imputed genotypes derived from the 1000 genomes project are an immediate research priority. This is encouraged by the detection of a haplotype association with coronary disease (<xref ref-type="bibr" rid="DDR384C55">55</xref>) that subsequently was partially explained as a synthetic association to an <italic>LPA</italic> SNP (<xref ref-type="bibr" rid="DDR384C30">30</xref>). Imputation-based analysis will be complemented by whole-genome or exome resequencing experiments aimed at identifying low-frequency variants and unique high-penetrance mutations; together, these approaches have the potential to reveal novel disease mechanisms.</p><p>Finally, as the list of mapped disease variants expands, and fine-mapping and functional genomic studies refine loci to resolve underlying genes, pathway and network analysis should prove useful to provide systems level insights into coronary disease pathogenesis (<xref ref-type="bibr" rid="DDR384C56">56</xref>,<xref ref-type="bibr" rid="DDR384C57">57</xref>).</p><p><italic>Conflict of Interest statement</italic>. None declared.</p></sec><sec id="s11"><title>FUNDING</title><p>This work was supported by the <funding-source>European Community Sixth Framework Program</funding-source> (<award-id>LSHM-CT-2007-037273</award-id>), the <funding-source>British Heart Foundation</funding-source>, the <funding-source>Oxford BHF Centre of Research Excellence and the Wellcome Trust</funding-source> (<award-id>090532/Z/09/Z</award-id>). Funding to pay the Open Access publication charges for this article was provided by the <funding-source>Wellcome Trust</funding-source>.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="DDR384C1"><label>1</label><element-citation publication-type="other"><collab>World Health Organization</collab><article-title>The 10 leading causes of death by broad income group (2004) Fact sheet no. 310</article-title><year>2008</year></element-citation></ref><ref id="DDR384C2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zdravkovic</surname><given-names>S.</given-names></name><name><surname>Wienke</surname><given-names>A.</given-names></name><name><surname>Pedersen</surname><given-names>N.L.</given-names></name><name><surname>Marenberg</surname><given-names>M.E.</given-names></name><name><surname>Yashin</surname><given-names>A.I.</given-names></name><name><surname>de Faire</surname><given-names>U.</given-names></name></person-group><article-title>Genetic influences on CHD-death and the impact of known risk factors: comparison of two frailty models</article-title><source>Behav. Genet.</source><year>2004</year><volume>34</volume><fpage>585</fpage><lpage>592</lpage><pub-id pub-id-type="pmid">15520515</pub-id></element-citation></ref><ref id="DDR384C3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schunkert</surname><given-names>H.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>I.R.</given-names></name><name><surname>Kathiresan</surname><given-names>S.</given-names></name><name><surname>Reilly</surname><given-names>M.P.</given-names></name><name><surname>Assimes</surname><given-names>T.L.</given-names></name><name><surname>Holm</surname><given-names>H.</given-names></name><name><surname>Preuss</surname><given-names>M.</given-names></name><name><surname>Stewart</surname><given-names>A.F.</given-names></name><name><surname>Barbalic</surname><given-names>M.</given-names></name><name><surname>Gieger</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease</article-title><source>Nat. Genet.</source><year>2011</year><volume>43</volume><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">21378990</pub-id></element-citation></ref><ref id="DDR384C4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peden</surname><given-names>J.F.</given-names></name><name><surname>Hopewell</surname><given-names>J.C.</given-names></name><name><surname>Saleheen</surname><given-names>D.</given-names></name><name><surname>Chambers</surname><given-names>J.C.</given-names></name><name><surname>Hager</surname><given-names>J.</given-names></name><name><surname>Soranzo</surname><given-names>N.</given-names></name><name><surname>Collins</surname><given-names>R.</given-names></name><name><surname>Danesh</surname><given-names>J.</given-names></name><name><surname>Elliott</surname><given-names>P.</given-names></name><name><surname>Farrall</surname><given-names>M.</given-names></name></person-group><article-title>A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease</article-title><source>Nat. Genet.</source><year>2011</year><volume>43</volume><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">21378988</pub-id></element-citation></ref><ref id="DDR384C5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erdmann</surname><given-names>J.</given-names></name><name><surname>Willenborg</surname><given-names>C.</given-names></name><name><surname>Nahrstaedt</surname><given-names>J.</given-names></name><name><surname>Preuss</surname><given-names>M.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>I.R.</given-names></name><name><surname>Baumert</surname><given-names>J.</given-names></name><name><surname>Linsel-Nitschke</surname><given-names>P.</given-names></name><name><surname>Gieger</surname><given-names>C.</given-names></name><name><surname>Tennstedt</surname><given-names>S.</given-names></name><name><surname>Belcredi</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23</article-title><source>Eur. Heart J.</source><year>2011</year><volume>32</volume><fpage>158</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">21088011</pub-id></element-citation></ref><ref id="DDR384C6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reilly</surname><given-names>M.P.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Ferguson</surname><given-names>J.F.</given-names></name><name><surname>Stylianou</surname><given-names>I.M.</given-names></name><name><surname>Mehta</surname><given-names>N.N.</given-names></name><name><surname>Burnett</surname><given-names>M.S.</given-names></name><name><surname>Devaney</surname><given-names>J.M.</given-names></name><name><surname>Knouff</surname><given-names>C.W.</given-names></name><name><surname>Thompson</surname><given-names>J.R.</given-names></name><etal/></person-group><article-title>Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies</article-title><source>Lancet</source><year>2011</year><volume>377</volume><fpage>383</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">21239051</pub-id></element-citation></ref><ref id="DDR384C7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>C.Q.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Cai</surname><given-names>J.P.</given-names></name><name><surname>Li</surname><given-names>X.C.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Xiong</surname><given-names>X.</given-names></name><name><surname>Liao</surname><given-names>Y.H.</given-names></name><name><surname>Zeng</surname><given-names>Q.T.</given-names></name><name><surname>Yang</surname><given-names>Y.Z.</given-names></name><etal/></person-group><article-title>Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population</article-title><source>Nat. Genet.</source><year>2011</year><volume>43</volume><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">21378986</pub-id></element-citation></ref><ref id="DDR384C8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterworth</surname><given-names>A.S.</given-names></name><name><surname>Braund</surname><given-names>P.S.</given-names></name><name><surname>Farrall</surname><given-names>M.</given-names></name><name><surname>Hardwick</surname><given-names>R.J.</given-names></name><name><surname>Saleheen</surname><given-names>D.</given-names></name><name><surname>Peden</surname><given-names>J.F.</given-names></name><name><surname>Soranzo</surname><given-names>N.</given-names></name><name><surname>Chambers</surname><given-names>J.C.</given-names></name><name><surname>Sivapalaratnam</surname><given-names>S.</given-names></name><name><surname>Kleber</surname><given-names>M.E.</given-names></name><etal/></person-group><article-title>Large-scale gene-centric analysis identifies novel variants for coronary artery disease</article-title><source>PLoS Genetics</source><year>2011</year><comment>(in press)</comment></element-citation></ref><ref id="DDR384C9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeller</surname><given-names>T.</given-names></name><name><surname>Wild</surname><given-names>P.</given-names></name><name><surname>Szymczak</surname><given-names>S.</given-names></name><name><surname>Rotival</surname><given-names>M.</given-names></name><name><surname>Schillert</surname><given-names>A.</given-names></name><name><surname>Castagne</surname><given-names>R.</given-names></name><name><surname>Maouche</surname><given-names>S.</given-names></name><name><surname>Germain</surname><given-names>M.</given-names></name><name><surname>Lackner</surname><given-names>K.</given-names></name><name><surname>Rossmann</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Genetics and beyond&#x02014;the transcriptome of human monocytes and disease susceptibility</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e10693</fpage><pub-id pub-id-type="pmid">20502693</pub-id></element-citation></ref><ref id="DDR384C10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadbent</surname><given-names>H.M.</given-names></name><name><surname>Peden</surname><given-names>J.F.</given-names></name><name><surname>Lorkowski</surname><given-names>S.</given-names></name><name><surname>Goel</surname><given-names>A.</given-names></name><name><surname>Ongen</surname><given-names>H.</given-names></name><name><surname>Green</surname><given-names>F.</given-names></name><name><surname>Clarke</surname><given-names>R.</given-names></name><name><surname>Collins</surname><given-names>R.</given-names></name><name><surname>Franzosi</surname><given-names>M.G.</given-names></name><name><surname>Tognoni</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p</article-title><source>Hum. Mol. Genet.</source><year>2008</year><volume>17</volume><fpage>806</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">18048406</pub-id></element-citation></ref><ref id="DDR384C11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noonan</surname><given-names>J.P.</given-names></name><name><surname>McCallion</surname><given-names>A.S.</given-names></name></person-group><article-title>Genomics of long-range regulatory elements</article-title><source>Annu. Rev. Genomics Hum. Genet.</source><year>2010</year><volume>11</volume><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">20438361</pub-id></element-citation></ref><ref id="DDR384C12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>J.E.</given-names></name><name><surname>Corces</surname><given-names>V.G.</given-names></name></person-group><article-title>CTCF: master weaver of the genome</article-title><source>Cell</source><year>2009</year><volume>137</volume><fpage>1194</fpage><lpage>1211</lpage><pub-id pub-id-type="pmid">19563753</pub-id></element-citation></ref><ref id="DDR384C13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrall</surname><given-names>M.</given-names></name><name><surname>Morris</surname><given-names>A.P.</given-names></name></person-group><article-title>Gearing up for genome-wide gene-association studies</article-title><source>Hum. Mol. Genet.</source><year>2005</year><volume>14</volume><issue>Spec no. 2</issue><fpage>R157</fpage><lpage>R162</lpage><pub-id pub-id-type="pmid">16244314</pub-id></element-citation></ref><ref id="DDR384C14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Wacholder</surname><given-names>S.</given-names></name><name><surname>Gail</surname><given-names>M.H.</given-names></name><name><surname>Peters</surname><given-names>U.</given-names></name><name><surname>Jacobs</surname><given-names>K.B.</given-names></name><name><surname>Chanock</surname><given-names>S.J.</given-names></name><name><surname>Chatterjee</surname><given-names>N.</given-names></name></person-group><article-title>Estimation of effect size distribution from genome-wide association studies and implications for future discoveries</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><fpage>570</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">20562874</pub-id></element-citation></ref><ref id="DDR384C15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudbridge</surname><given-names>F.</given-names></name><name><surname>Gusnanto</surname><given-names>A.</given-names></name></person-group><article-title>Estimation of significance thresholds for genomewide association scans</article-title><source>Genet. Epidemiol.</source><year>2008</year><volume>32</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">18300295</pub-id></element-citation></ref><ref id="DDR384C16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skol</surname><given-names>A.D.</given-names></name><name><surname>Scott</surname><given-names>L.J.</given-names></name><name><surname>Abecasis</surname><given-names>G.R.</given-names></name><name><surname>Boehnke</surname><given-names>M.</given-names></name></person-group><article-title>Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies</article-title><source>Nat. Genet.</source><year>2006</year><volume>38</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">16415888</pub-id></element-citation></ref><ref id="DDR384C17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colhoun</surname><given-names>H.M.</given-names></name><name><surname>McKeigue</surname><given-names>P.M.</given-names></name><name><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>Problems of reporting genetic associations with complex outcomes</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>865</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">12642066</pub-id></element-citation></ref><ref id="DDR384C18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolio</surname><given-names>T.A.</given-names></name><name><surname>Collins</surname><given-names>F.S.</given-names></name><name><surname>Cox</surname><given-names>N.J.</given-names></name><name><surname>Goldstein</surname><given-names>D.B.</given-names></name><name><surname>Hindorff</surname><given-names>L.A.</given-names></name><name><surname>Hunter</surname><given-names>D.J.</given-names></name><name><surname>McCarthy</surname><given-names>M.I.</given-names></name><name><surname>Ramos</surname><given-names>E.M.</given-names></name><name><surname>Cardon</surname><given-names>L.R.</given-names></name><name><surname>Chakravarti</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Finding the missing heritability of complex diseases</article-title><source>Nature</source><year>2009</year><volume>461</volume><fpage>747</fpage><lpage>753</lpage><pub-id pub-id-type="pmid">19812666</pub-id></element-citation></ref><ref id="DDR384C19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>H.</given-names></name><name><surname>Prentice</surname><given-names>R.L.</given-names></name></person-group><article-title>Correcting &#x02018;winner's curse&#x02019; in odds ratios from genomewide association findings for major complex human diseases</article-title><source>Genet. Epidemiol.</source><year>2010</year><volume>34</volume><fpage>78</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">19639606</pub-id></element-citation></ref><ref id="DDR384C20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moskvina</surname><given-names>V.</given-names></name><name><surname>Holmans</surname><given-names>P.</given-names></name><name><surname>Schmidt</surname><given-names>K.M.</given-names></name><name><surname>Craddock</surname><given-names>N.</given-names></name></person-group><article-title>Design of case&#x02013;controls studies with unscreened controls</article-title><source>Ann. Hum. Genet.</source><year>2005</year><volume>69</volume><fpage>566</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">16138915</pub-id></element-citation></ref><ref id="DDR384C21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zdravkovic</surname><given-names>S.</given-names></name><name><surname>Wienke</surname><given-names>A.</given-names></name><name><surname>Pedersen</surname><given-names>N.L.</given-names></name><name><surname>de Faire</surname><given-names>U.</given-names></name></person-group><article-title>Genetic influences on angina pectoris and its impact on coronary heart disease</article-title><source>Eur. J. Hum. Genet.</source><year>2007</year><volume>15</volume><fpage>872</fpage><lpage>877</lpage><pub-id pub-id-type="pmid">17487220</pub-id></element-citation></ref><ref id="DDR384C22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zdravkovic</surname><given-names>S.</given-names></name><name><surname>Wienke</surname><given-names>A.</given-names></name><name><surname>Pedersen</surname><given-names>N.L.</given-names></name><name><surname>Marenberg</surname><given-names>M.E.</given-names></name><name><surname>Yashin</surname><given-names>A.I.</given-names></name><name><surname>De Faire</surname><given-names>U.</given-names></name></person-group><article-title>Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins</article-title><source>J. Intern. Med.</source><year>2002</year><volume>252</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">12270005</pub-id></element-citation></ref><ref id="DDR384C23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voight</surname><given-names>B.F.</given-names></name><name><surname>Scott</surname><given-names>L.J.</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V.</given-names></name><name><surname>Morris</surname><given-names>A.P.</given-names></name><name><surname>Dina</surname><given-names>C.</given-names></name><name><surname>Welch</surname><given-names>R.P.</given-names></name><name><surname>Zeggini</surname><given-names>E.</given-names></name><name><surname>Huth</surname><given-names>C.</given-names></name><name><surname>Aulchenko</surname><given-names>Y.S.</given-names></name><name><surname>Thorleifsson</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis</article-title><source>Nat. Genet.</source><year>2010</year><volume>42</volume><fpage>579</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">20581827</pub-id></element-citation></ref><ref id="DDR384C24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>N.G.</given-names></name><name><surname>Eaves</surname><given-names>L.J.</given-names></name><name><surname>Kearsey</surname><given-names>M.J.</given-names></name><name><surname>Davies</surname><given-names>P.</given-names></name></person-group><article-title>The power of the classical twin study</article-title><source>Heredity</source><year>1978</year><volume>40</volume><fpage>97</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">272366</pub-id></element-citation></ref><ref id="DDR384C25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>K.</given-names></name><name><surname>Toyoda</surname><given-names>H.</given-names></name><name><surname>Iwama</surname><given-names>N.</given-names></name><name><surname>Kubo</surname><given-names>S.</given-names></name><name><surname>Ando</surname><given-names>J.</given-names></name></person-group><article-title>Using non-normal SEM to resolve the ACDE model in the classical twin design</article-title><source>Behav. Genet.</source><year>2011</year><volume>41</volume><fpage>329</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">20703791</pub-id></element-citation></ref><ref id="DDR384C26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samani</surname><given-names>N.J.</given-names></name><name><surname>Burton</surname><given-names>P.</given-names></name><name><surname>Mangino</surname><given-names>M.</given-names></name><name><surname>Ball</surname><given-names>S.G.</given-names></name><name><surname>Balmforth</surname><given-names>A.J.</given-names></name><name><surname>Barrett</surname><given-names>J.</given-names></name><name><surname>Bishop</surname><given-names>T.</given-names></name><name><surname>Hall</surname><given-names>A.</given-names></name></person-group><collab>BHF Family Heart Study Research Group</collab><article-title>A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study</article-title><source>Am. J. Hum. Genet.</source><year>2005</year><volume>77</volume><fpage>1011</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">16380912</pub-id></element-citation></ref><ref id="DDR384C27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrall</surname><given-names>M.</given-names></name><name><surname>Green</surname><given-names>F.R.</given-names></name><name><surname>Peden</surname><given-names>J.F.</given-names></name><name><surname>Olsson</surname><given-names>P.G.</given-names></name><name><surname>Clarke</surname><given-names>R.</given-names></name><name><surname>Hellenius</surname><given-names>M.L.</given-names></name><name><surname>Rust</surname><given-names>S.</given-names></name><name><surname>Lagercrantz</surname><given-names>J.</given-names></name><name><surname>Franzosi</surname><given-names>M.G.</given-names></name><name><surname>Schulte</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17</article-title><source>PLoS Genet.</source><year>2006</year><volume>2</volume><fpage>e72</fpage><pub-id pub-id-type="pmid">16710446</pub-id></element-citation></ref><ref id="DDR384C28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>I.P.</given-names></name><name><surname>Whittemore</surname><given-names>A.S.</given-names></name></person-group><article-title>Power of association and linkage tests when the disease alleles are unobserved</article-title><source>Am. J. Hum. Genet.</source><year>1999</year><volume>64</volume><fpage>641</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">9973303</pub-id></element-citation></ref><ref id="DDR384C29"><label>29</label><element-citation publication-type="journal"><collab>Wellcome Trust Case Control Consortium</collab><article-title>Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls</article-title><source>Nature</source><year>2010</year><volume>464</volume><fpage>713</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">20360734</pub-id></element-citation></ref><ref id="DDR384C30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>R.</given-names></name><name><surname>Peden</surname><given-names>J.F.</given-names></name><name><surname>Hopewell</surname><given-names>J.C.</given-names></name><name><surname>Kyriakou</surname><given-names>T.</given-names></name><name><surname>Goel</surname><given-names>A.</given-names></name><name><surname>Heath</surname><given-names>S.C.</given-names></name><name><surname>Parish</surname><given-names>S.</given-names></name><name><surname>Barlera</surname><given-names>S.</given-names></name><name><surname>Franzosi</surname><given-names>M.G.</given-names></name><name><surname>Rust</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Genetic variants associated with Lp(a) lipoprotein level and coronary disease</article-title><source>N. Engl. J. Med.</source><year>2009</year><volume>361</volume><fpage>2518</fpage><lpage>2528</lpage><pub-id pub-id-type="pmid">20032323</pub-id></element-citation></ref><ref id="DDR384C31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanktree</surname><given-names>M.B.</given-names></name><name><surname>Rajakumar</surname><given-names>C.</given-names></name><name><surname>Brunt</surname><given-names>J.H.</given-names></name><name><surname>Koschinsky</surname><given-names>M.L.</given-names></name><name><surname>Connelly</surname><given-names>P.W.</given-names></name><name><surname>Hegele</surname><given-names>R.A.</given-names></name></person-group><article-title>Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR</article-title><source>J. Lipid Res.</source><year>2009</year><volume>50</volume><fpage>768</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">19060253</pub-id></element-citation></ref><ref id="DDR384C32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamstrup</surname><given-names>P.R.</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A.</given-names></name><name><surname>Steffensen</surname><given-names>R.</given-names></name><name><surname>Nordestgaard</surname><given-names>B.G.</given-names></name></person-group><article-title>Genetically elevated lipoprotein(a) and increased risk of myocardial infarction</article-title><source>J. Am. Med. Assoc.</source><year>2009</year><volume>301</volume><fpage>2331</fpage><lpage>2339</lpage></element-citation></ref><ref id="DDR384C33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lango Allen</surname><given-names>H.</given-names></name><name><surname>Estrada</surname><given-names>K.</given-names></name><name><surname>Lettre</surname><given-names>G.</given-names></name><name><surname>Berndt</surname><given-names>S.I.</given-names></name><name><surname>Weedon</surname><given-names>M.N.</given-names></name><name><surname>Rivadeneira</surname><given-names>F.</given-names></name><name><surname>Willer</surname><given-names>C.J.</given-names></name><name><surname>Jackson</surname><given-names>A.U.</given-names></name><name><surname>Vedantam</surname><given-names>S.</given-names></name><name><surname>Raychaudhuri</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Hundreds of variants clustered in genomic loci and biological pathways affect human height</article-title><source>Nature</source><year>2010</year><volume>467</volume><fpage>832</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">20881960</pub-id></element-citation></ref><ref id="DDR384C34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>S.</given-names></name></person-group><collab>Myocardial Infarction Genetics Consortium</collab><article-title>A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction</article-title><source>N. Engl. J. Med.</source><year>2008</year><volume>358</volume><fpage>2299</fpage><lpage>2300</lpage><pub-id pub-id-type="pmid">18499582</pub-id></element-citation></ref><ref id="DDR384C35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benn</surname><given-names>M.</given-names></name><name><surname>Nordestgaard</surname><given-names>B.G.</given-names></name><name><surname>Grande</surname><given-names>P.</given-names></name><name><surname>Schnohr</surname><given-names>P.</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A.</given-names></name></person-group><article-title>PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses</article-title><source>J. Am. Coll. Cardiol.</source><year>2010</year><volume>55</volume><fpage>2833</fpage><lpage>2842</lpage><pub-id pub-id-type="pmid">20579540</pub-id></element-citation></ref><ref id="DDR384C36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>S.</given-names></name><name><surname>Voight</surname><given-names>B.F.</given-names></name><name><surname>Purcell</surname><given-names>S.</given-names></name><name><surname>Musunuru</surname><given-names>K.</given-names></name><name><surname>Ardissino</surname><given-names>D.</given-names></name><name><surname>Mannucci</surname><given-names>P.M.</given-names></name><name><surname>Anand</surname><given-names>S.</given-names></name><name><surname>Engert</surname><given-names>J.C.</given-names></name><name><surname>Samani</surname><given-names>N.J.</given-names></name><etal/></person-group><collab>Myocardial Infarction Genetics Consortium</collab><article-title>Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>334</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">19198609</pub-id></element-citation></ref><ref id="DDR384C37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virmani</surname><given-names>R.</given-names></name><name><surname>Kolodgie</surname><given-names>F.D.</given-names></name><name><surname>Burke</surname><given-names>A.P.</given-names></name><name><surname>Farb</surname><given-names>A.</given-names></name><name><surname>Schwartz</surname><given-names>S.M.</given-names></name></person-group><article-title>Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2000</year><volume>20</volume><fpage>1262</fpage><lpage>1275</lpage><pub-id pub-id-type="pmid">10807742</pub-id></element-citation></ref><ref id="DDR384C38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton-Cheh</surname><given-names>C.</given-names></name><name><surname>Johnson</surname><given-names>T.</given-names></name><name><surname>Gateva</surname><given-names>V.</given-names></name><name><surname>Tobin</surname><given-names>M.D.</given-names></name><name><surname>Bochud</surname><given-names>M.</given-names></name><name><surname>Coin</surname><given-names>L.</given-names></name><name><surname>Najjar</surname><given-names>S.S.</given-names></name><name><surname>Zhao</surname><given-names>J.H.</given-names></name><name><surname>Heath</surname><given-names>S.C.</given-names></name><name><surname>Eyheramendy</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Genome-wide association study identifies eight loci associated with blood pressure</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>666</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">19430483</pub-id></element-citation></ref><ref id="DDR384C39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Ehret</surname><given-names>G.B.</given-names></name><name><surname>Rice</surname><given-names>K.</given-names></name><name><surname>Verwoert</surname><given-names>G.C.</given-names></name><name><surname>Launer</surname><given-names>L.J.</given-names></name><name><surname>Dehghan</surname><given-names>A.</given-names></name><name><surname>Glazer</surname><given-names>N.L.</given-names></name><name><surname>Morrison</surname><given-names>A.C.</given-names></name><name><surname>Johnson</surname><given-names>A.D.</given-names></name><name><surname>Aspelund</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Genome-wide association study of blood pressure and hypertension</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>677</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">19430479</pub-id></element-citation></ref><ref id="DDR384C40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teslovich</surname><given-names>T.M.</given-names></name><name><surname>Musunuru</surname><given-names>K.</given-names></name><name><surname>Smith</surname><given-names>A.V.</given-names></name><name><surname>Edmondson</surname><given-names>A.C.</given-names></name><name><surname>Stylianou</surname><given-names>I.M.</given-names></name><name><surname>Koseki</surname><given-names>M.</given-names></name><name><surname>Pirruccello</surname><given-names>J.P.</given-names></name><name><surname>Ripatti</surname><given-names>S.</given-names></name><name><surname>Chasman</surname><given-names>D.I.</given-names></name><name><surname>Willer</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>Biological, clinical and population relevance of 95 loci for blood lipids</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">20686565</pub-id></element-citation></ref><ref id="DDR384C41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>W.Y.</given-names></name><name><surname>Sharpless</surname><given-names>N.E.</given-names></name></person-group><article-title>The regulation of INK4/ARF in cancer and aging</article-title><source>Cell</source><year>2006</year><volume>127</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">17055429</pub-id></element-citation></ref><ref id="DDR384C42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasmant</surname><given-names>E.</given-names></name><name><surname>Laurendeau</surname><given-names>I.</given-names></name><name><surname>H&#x000e9;ron</surname><given-names>D.</given-names></name><name><surname>Vidaud</surname><given-names>M.</given-names></name><name><surname>Vidaud</surname><given-names>D.</given-names></name><name><surname>Bi&#x000e8;che</surname><given-names>I.</given-names></name></person-group><article-title>Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF</article-title><source>Cancer Res.</source><year>2007</year><volume>67</volume><fpage>3963</fpage><lpage>3969</lpage><pub-id pub-id-type="pmid">17440112</pub-id></element-citation></ref><ref id="DDR384C43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visel</surname><given-names>A.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>May</surname><given-names>D.</given-names></name><name><surname>Afzal</surname><given-names>V.</given-names></name><name><surname>Gong</surname><given-names>E.</given-names></name><name><surname>Attanasio</surname><given-names>C.</given-names></name><name><surname>Blow</surname><given-names>M.J.</given-names></name><name><surname>Cohen</surname><given-names>J.C.</given-names></name><name><surname>Rubin</surname><given-names>E.M.</given-names></name><name><surname>Pennacchio</surname><given-names>L.A.</given-names></name></person-group><article-title>Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice</article-title><source>Nature</source><year>2010</year><volume>464</volume><fpage>409</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">20173736</pub-id></element-citation></ref><ref id="DDR384C44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harismendy</surname><given-names>O.</given-names></name><name><surname>Notani</surname><given-names>D.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Rahim</surname><given-names>N.G.</given-names></name><name><surname>Tanasa</surname><given-names>B.</given-names></name><name><surname>Heintzman</surname><given-names>N.</given-names></name><name><surname>Ren</surname><given-names>B.</given-names></name><name><surname>Fu</surname><given-names>X.D.</given-names></name><name><surname>Topol</surname><given-names>E.J.</given-names></name><name><surname>Rosenfeld</surname><given-names>M.G.</given-names></name><name><surname>Frazer</surname><given-names>K.A.</given-names></name></person-group><article-title>9p21 DNA variants associated with coronary artery disease impair interferon-&#x003b3; signalling response</article-title><source>Nature</source><year>2011</year><volume>470</volume><fpage>264</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">21307941</pub-id></element-citation></ref><ref id="DDR384C45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musunuru</surname><given-names>K.</given-names></name><name><surname>Strong</surname><given-names>A.</given-names></name><name><surname>Frank-Kamenetsky</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>N.E.</given-names></name><name><surname>Ahfeldt</surname><given-names>T.</given-names></name><name><surname>Sachs</surname><given-names>K.V.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Kuperwasser</surname><given-names>N.</given-names></name><name><surname>Ruda</surname><given-names>V.M.</given-names></name><etal/></person-group><article-title>From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>714</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">20686566</pub-id></element-citation></ref><ref id="DDR384C46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjolby</surname><given-names>M.</given-names></name><name><surname>Andersen</surname><given-names>O.M.</given-names></name><name><surname>Breiderhoff</surname><given-names>T.</given-names></name><name><surname>Fjorback</surname><given-names>A.W.</given-names></name><name><surname>Pedersen</surname><given-names>K.M.</given-names></name><name><surname>Madsen</surname><given-names>P.</given-names></name><name><surname>Jansen</surname><given-names>P.</given-names></name><name><surname>Heeren</surname><given-names>J.</given-names></name><name><surname>Willnow</surname><given-names>T.E.</given-names></name><name><surname>Nykjaer</surname><given-names>A.</given-names></name></person-group><article-title>Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export</article-title><source>Cell Metab.</source><year>2010</year><volume>12</volume><fpage>213</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">20816088</pub-id></element-citation></ref><ref id="DDR384C47"><label>47</label><element-citation publication-type="journal"><collab>NCEP Expert Panel</collab><article-title>Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)</article-title><source>J. Am. Med. Assoc.</source><year>2001</year><volume>285</volume><fpage>2486</fpage><lpage>2497</lpage></element-citation></ref><ref id="DDR384C48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>S.</given-names></name><name><surname>Melander</surname><given-names>O.</given-names></name><name><surname>Anevski</surname><given-names>D.</given-names></name><name><surname>Guiducci</surname><given-names>C.</given-names></name><name><surname>Burtt</surname><given-names>N.P.</given-names></name><name><surname>Roos</surname><given-names>C.</given-names></name><name><surname>Hirschhorn</surname><given-names>J.N.</given-names></name><name><surname>Berglund</surname><given-names>G.</given-names></name><name><surname>Hedblad</surname><given-names>B.</given-names></name><name><surname>Groop</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Polymorphisms associated with cholesterol and risk of cardiovascular events</article-title><source>N. Engl. J. Med.</source><year>2008</year><volume>358</volume><fpage>1240</fpage><lpage>1249</lpage><pub-id pub-id-type="pmid">18354102</pub-id></element-citation></ref><ref id="DDR384C49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>R.</given-names></name><name><surname>Shipley</surname><given-names>M.</given-names></name><name><surname>Lewington</surname><given-names>S.</given-names></name><name><surname>Youngman</surname><given-names>L.</given-names></name><name><surname>Collins</surname><given-names>R.</given-names></name><name><surname>Marmot</surname><given-names>M.</given-names></name><name><surname>Peto</surname><given-names>R.</given-names></name></person-group><article-title>Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies</article-title><source>Am. J. Epidemiol.</source><year>1999</year><volume>150</volume><fpage>341</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">10453810</pub-id></element-citation></ref><ref id="DDR384C50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>G.D.</given-names></name><name><surname>Ebrahim</surname><given-names>S.</given-names></name></person-group><article-title>Mendelian randomization: prospects, potentials, and limitations</article-title><source>Int. J. Epidemiol.</source><year>2004</year><volume>33</volume><fpage>30</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">15075143</pub-id></element-citation></ref><ref id="DDR384C51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>H.</given-names></name><name><surname>Farrall</surname><given-names>M.</given-names></name></person-group><article-title>Genetic susceptibility to coronary artery disease: from promise to progress</article-title><source>Nat. Rev. Genet.</source><year>2006</year><volume>7</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">16462853</pub-id></element-citation></ref><ref id="DDR384C52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntzani</surname><given-names>E.E.</given-names></name><name><surname>Rizos</surname><given-names>E.C.</given-names></name><name><surname>Ioannidis</surname><given-names>J.P.A.</given-names></name></person-group><article-title>Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence</article-title><source>Am. J. Epidemiol.</source><year>2007</year><volume>165</volume><fpage>973</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">17293603</pub-id></element-citation></ref><ref id="DDR384C53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennet</surname><given-names>A.M.</given-names></name><name><surname>Di Angelantonio</surname><given-names>E.</given-names></name><name><surname>Ye</surname><given-names>Z.</given-names></name><name><surname>Wensley</surname><given-names>F.</given-names></name><name><surname>Dahlin</surname><given-names>A.</given-names></name><name><surname>Ahlbom</surname><given-names>A.</given-names></name><name><surname>Keavney</surname><given-names>B.</given-names></name><name><surname>Collins</surname><given-names>R.</given-names></name><name><surname>Wiman</surname><given-names>B.</given-names></name><name><surname>de Faire</surname><given-names>U.</given-names></name><name><surname>Danesh</surname><given-names>J.</given-names></name></person-group><article-title>Association of apolipoprotein E genotypes with lipid levels and coronary risk</article-title><source>J. Am. Med. Assoc.</source><year>2007</year><volume>298</volume><fpage>1300</fpage><lpage>1311</lpage></element-citation></ref><ref id="DDR384C54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orozco</surname><given-names>G.</given-names></name><name><surname>Barrett</surname><given-names>J.C.</given-names></name><name><surname>Zeggini</surname><given-names>E.</given-names></name></person-group><article-title>Synthetic associations in the context of genome-wide association scan signals</article-title><source>Hum. Mol. Genet.</source><year>2010</year><volume>19</volume><fpage>R137</fpage><lpage>R144</lpage><pub-id pub-id-type="pmid">20805105</pub-id></element-citation></ref><ref id="DDR384C55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tr&#x000e9;gou&#x000eb;t</surname><given-names>D.A.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>I.R.</given-names></name><name><surname>Erdmann</surname><given-names>J.</given-names></name><name><surname>Munteanu</surname><given-names>A.</given-names></name><name><surname>Braund</surname><given-names>P.S.</given-names></name><name><surname>Hall</surname><given-names>A.S.</given-names></name><name><surname>Grosshennig</surname><given-names>A.</given-names></name><name><surname>Linsel-Nitschke</surname><given-names>P.</given-names></name><name><surname>Perret</surname><given-names>C.</given-names></name><name><surname>DeSuremain</surname><given-names>M.</given-names></name></person-group><article-title>Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>283</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">19198611</pub-id></element-citation></ref><ref id="DDR384C56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torkamani</surname><given-names>A.</given-names></name><name><surname>Schork</surname><given-names>N.J.</given-names></name></person-group><article-title>Pathway and network analysis with high-density allelic association data</article-title><source>Methods Mol. Biol.</source><year>2009</year><volume>563</volume><fpage>289</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">19597792</pub-id></element-citation></ref><ref id="DDR384C57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantor</surname><given-names>R.M.</given-names></name><name><surname>Lange</surname><given-names>K.</given-names></name><name><surname>Sinsheimer</surname><given-names>J.S.</given-names></name></person-group><article-title>Prioritizing GWAS results: a review of statistical methods and recommendations for their application</article-title><source>Am. J. Hum. Genet.</source><year>2010</year><volume>86</volume><fpage>6</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">20074509</pub-id></element-citation></ref><ref id="DDR384C58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samani</surname><given-names>N.J.</given-names></name><name><surname>Erdmann</surname><given-names>J.</given-names></name><name><surname>Hall</surname><given-names>A.S.</given-names></name><name><surname>Hengstenberg</surname><given-names>C.</given-names></name><name><surname>Mangino</surname><given-names>M.</given-names></name><name><surname>Mayer</surname><given-names>B.</given-names></name><name><surname>Dixon</surname><given-names>R.J.</given-names></name><name><surname>Meitinger</surname><given-names>T.</given-names></name><name><surname>Braund</surname><given-names>P.</given-names></name><name><surname>Wichmann</surname><given-names>H.E.</given-names></name><etal/></person-group><article-title>Genomewide association analysis of coronary artery disease</article-title><source>N. Engl. J. Med.</source><year>2007</year><volume>357</volume><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">17634449</pub-id></element-citation></ref><ref id="DDR384C59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erdmann</surname><given-names>J.</given-names></name><name><surname>Grosshennig</surname><given-names>A.</given-names></name><name><surname>Braund</surname><given-names>P.S.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>I.R.</given-names></name><name><surname>Hengstenberg</surname><given-names>C.</given-names></name><name><surname>Hall</surname><given-names>A.S.</given-names></name><name><surname>Linsel-Nitschke</surname><given-names>P.</given-names></name><name><surname>Kathiresan</surname><given-names>S.</given-names></name><name><surname>Wright</surname><given-names>B.</given-names></name><name><surname>Tr&#x000e9;gou&#x000eb;t</surname><given-names>D.A.</given-names></name><etal/></person-group><article-title>New susceptibility locus for coronary artery disease on chromosome 3q22.3</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>280</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">19198612</pub-id></element-citation></ref><ref id="DDR384C60"><label>60</label><element-citation publication-type="journal"><collab>Wellcome Trust Case-control Consortium</collab><article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>661</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">17554300</pub-id></element-citation></ref><ref id="DDR384C61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname><given-names>R.</given-names></name><name><surname>Pertsemlidis</surname><given-names>A.</given-names></name><name><surname>Kavaslar</surname><given-names>N.</given-names></name><name><surname>Stewart</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>R.</given-names></name><name><surname>Cox</surname><given-names>D.R.</given-names></name><name><surname>Hinds</surname><given-names>D.A.</given-names></name><name><surname>Pennacchio</surname><given-names>L.A.</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A.</given-names></name><name><surname>Folsom</surname><given-names>A.R.</given-names></name><etal/></person-group><article-title>A common allele on chromosome 9 associated with coronary heart disease</article-title><source>&#x000a0;Science</source><year>2007</year><volume>316</volume><fpage>1488</fpage><lpage>1491</lpage><pub-id pub-id-type="pmid">17478681</pub-id></element-citation></ref><ref id="DDR384C62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helgadottir</surname><given-names>A.</given-names></name><name><surname>Thorleifsson</surname><given-names>G.</given-names></name><name><surname>Manolescu</surname><given-names>A.</given-names></name><name><surname>Gretarsdottir</surname><given-names>S.</given-names></name><name><surname>Blondal</surname><given-names>T.</given-names></name><name><surname>Jonasdottir</surname><given-names>A.</given-names></name><name><surname>Jonasdottir</surname><given-names>A.</given-names></name><name><surname>Sigurdsson</surname><given-names>A.</given-names></name><name><surname>Baker</surname><given-names>A.</given-names></name><name><surname>Palsson</surname><given-names>A.</given-names></name><etal/></person-group><article-title>A common variant on chromosome 9p21 affects the risk of myocardial infarction</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1491</fpage><lpage>1493</lpage><pub-id pub-id-type="pmid">17478679</pub-id></element-citation></ref><ref id="DDR384C63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soranzo</surname><given-names>N.</given-names></name><name><surname>Spector</surname><given-names>T.D.</given-names></name><name><surname>Mangino</surname><given-names>M.</given-names></name><name><surname>K&#x000fc;hnel</surname><given-names>B.</given-names></name><name><surname>Rendon</surname><given-names>A.</given-names></name><name><surname>Teumer</surname><given-names>A.</given-names></name><name><surname>Willenborg</surname><given-names>C.</given-names></name><name><surname>Wright</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>1182</fpage><lpage>1190</lpage><pub-id pub-id-type="pmid">19820697</pub-id></element-citation></ref><ref id="DDR384C64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>S.</given-names></name><name><surname>Melander</surname><given-names>O.</given-names></name><name><surname>Guiducci</surname><given-names>C.</given-names></name><name><surname>Surti</surname><given-names>A.</given-names></name><name><surname>Burtt</surname><given-names>N.P.</given-names></name><name><surname>Rieder</surname><given-names>M.J.</given-names></name><name><surname>Cooper</surname><given-names>G.M.</given-names></name><name><surname>Roos</surname><given-names>C.</given-names></name><name><surname>Voight</surname><given-names>B.F.</given-names></name><name><surname>Havulinna</surname><given-names>A.S.</given-names></name><etal/></person-group><article-title>Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans</article-title><source>Nat. Genet.</source><year>2008</year><volume>40</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">18193044</pub-id></element-citation></ref></ref-list></back></article>